BioMarin Pharmaceuticals
BMRN
BMRN
547 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 214 increasing their positions, 175 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
547
Holders Change
+9
Holders Change %
+1.67%
% of All Funds
9.46%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.22%
New
63
Increased
214
Reduced
175
Closed
50
Calls
$134M
Puts
$101M
Net Calls
+$33M
Net Calls Change
+$42.1M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$344M |
| 2 |
Amundi
Paris,
France
|
+$130M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$83.7M |
| 4 |
Man Group
London,
United Kingdom
|
+$46.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$37.9M |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$135M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$59.3M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$44.5M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$24.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$24.4M |
